World Allergy Diagnostic Market - Opportunities and Forecasts, 2014 - 2020

Allergy is an exaggerated response of immune systems, which causes skin irritation, hay-fever, asthma, anaphylaxis and other symptoms. Therefore, it needs to be diagnosed and treated properly. In order to detect an allergy, skin tests and blood tests are performed by the healthcare providers. Rapidly increasing allergy incidences and changes in dietary habits are the major factors driving the growth of allergy diagnostics market. Furthermore, increasing environmental pollution, favourable reimbursements across major geographies and rising geriatric population also drives the market growth. However, high capital investment and stringent regulatory guidelines are the main factors restraining the market growth.

The world allergic diagnostic market is segmented into allergen types, product, instrument, end-user and geography. On the basis of allergen types, the market is segmented into drug allergen, food allergen, inhaled allergen, and others. Based on product, the allergy diagnostic market is segmented into assay kits, consumables, and instruments. The market for instruments is further sub-segmented into immunoassay analyzers, luminometers, and others. Based on end user, the market is segmented across academic institutes, diagnostic laboratories, and hospitals. Geographically, the report is segmented into four regions namely North America, Europe, Asia-Pacific, and LAMEA. Presently, North America occupies a major share of the market followed by Europe and Asia-Pacific.

In 2015, Siemens Healthcare Diagnostics launched its next generation of chemistry and immunoassay systems to achieve high level of workflow efficiency in United Kingdom. Top players in this market include Alerchek Inc., bioMerieux, Inc., Danaher Corp., DST Diagnostische Systeme & Technologien GmbH, Hitachi chemical Diagnostic Inc., HOB Biotech Group Co. Ltd., Hycor Biomedical Inc., Lincoln Diagnostics Inc., Omega Diagnostic Llc, Siemens Healthcare Diagnostics, Inc., Stallergenes SA, and Thermo Fisher Scientific Inc.

KEY MARKET BENEFITS:

• Comprehensive analysis of factors that drive and restrict the growth of the world allergy diagnostic market is provided in the report.
• Competitive intelligence among the top players helps in understanding the competitive scenario across the geographies.
• SWOT analysis highlights the internal environment of leading companies for effective strategy formulation.
• The report provides the quantitative analysis of the current market and estimations through 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities.
• Comprehensive analysis of all geographic regions are provided that helps in determining the prevailing opportunities in these geographies.

KEY MARKET SEGMENTS:World allergy diagnostic market is segmented below:

• By Allergen Type
  • Drug Allergen
  • Food Allergen
    • A) Plant Origin
    • B) Food Origin
  • Inhaled Allergen
    • A) Plant Origin
    • B) Food Origin
  • Others

• By Product Type
  • Assay kits
  • Consumables
  • Instruments
    • A) Immunoassay Analyzers
    • B) Luminometers
    • C) Others

• By End-user
  • Academic Institutes
  • Diagnostic Laboratories
  • Hospitals

• By Geography
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Others
  • Asia Pacific
    • China
    • India
    • Japan
    • Others
  • LAMEA
    • Brazil
    • South Africa
    • Others